Cargando…

Cancer burden and status of cancer control measures in fragile states: a comparative analysis of 31 countries

BACKGROUND: Information on cancer statistics and cancer control policies is limited in fragile states. This paper describes the cancer burden and status of cancer control measures in these countries. METHODS: In this comparative analysis, fragile states presenting with a Fragile States Index (FSI) s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosquera, Isabel, Ilbawi, Andre, Muwonge, Richard, Basu, Partha, Carvalho, Andre L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638035/ https://www.ncbi.nlm.nih.gov/pubmed/36113529 http://dx.doi.org/10.1016/S2214-109X(22)00331-X

Ejemplares similares

Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study group
por: Villain, Patricia, et al.
Publicado: (2021)

An international consensus on the essential and desirable criteria for an ‘organized’ cancer screening programme
por: Zhang, Li, et al.
Publicado: (2022)

A pragmatic approach to tackle the rising burden of breast cancer through prevention & early detection in countries ‘in transition’
por: Basu, Partha, et al.
Publicado: (2020)

CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs
por: Zhang, Li, et al.
Publicado: (2023)

Assessment of organization of cervical and breast cancer screening programmes in the Latin American and the Caribbean states: The CanScreen5 framework
por: Mosquera, Isabel, et al.
Publicado: (2023)

The development and education of a workforce in childhood cancer services in low- and middle-income countries: a scoping review protocol
por: Cayrol, Julie, et al.
Publicado: (2022)

Delays and Barriers to Cancer Care in Low‐ and Middle‐Income Countries: A Systematic Review
por: Brand, Nathan R., et al.
Publicado: (2019)

Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance
por: Basu, Partha, et al.
Publicado: (2018)

Components and effectiveness of patient navigation programmes to increase participation to breast, cervical and colorectal cancer screening: A systematic review
por: Mosquera, Isabel, et al.
Publicado: (2023)

Training health care providers to administer VIA as a screening test for cervical cancer: a systematic review of essential training components
por: Brevik, Thea Beate, et al.
Publicado: (2023)

Childhood cancer control during the COVID-19 pandemic
por: Luna-Fineman, Sandra, et al.
Publicado: (2021)

Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reports
por: Elit, Laurie, et al.
Publicado: (2020)

Leveraging vertical COVID-19 investments to improve monitoring of cancer screening programme – A case study from Bangladesh
por: Basu, Partha, et al.
Publicado: (2021)

Cost-effective interventions for breast cancer, cervical cancer, and colorectal cancer: new results from WHO-CHOICE
por: Ralaidovy, Ambinintsoa H., et al.
Publicado: (2018)

Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies
por: Tay-Teo, Kiu, et al.
Publicado: (2019)

Interstate Variation in the Burden of Fragility Fractures
por: King, Alison B, et al.
Publicado: (2009)

Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation
por: Basu, Partha, et al.
Publicado: (2021)

Agreement between Self- and PhysicianSampling for Detection of HighRisk Human Papillomavirus Infections in Women Attending Cervical Screening at National Cancer Institute, Thailand
por: Sangrajrang, Suleeporn, et al.
Publicado: (2023)

Fragility fractures in Europe: burden, management and opportunities
por: Borgström, Fredrik, et al.
Publicado: (2020)

Epidemiology and economic burden of fragility fractures in Austria
por: Muschitz, C., et al.
Publicado: (2021)

Effectiveness of Artificial Intelligence–Assisted Decision-making to Improve Vulnerable Women’s Participation in Cervical Cancer Screening in France: Protocol for a Cluster Randomized Controlled Trial (AppDate-You)
por: Selmouni, Farida, et al.
Publicado: (2022)

A Prospective Randomized Trial to Compare Safety, Acceptability and Efficacy of Thermal Ablation and Cryotherapy in a Screen and Treat Setting
por: Banerjee, Dipanwita, et al.
Publicado: (2020)

The comparative burden of salmonellosis in the European Union member states, associated and candidate countries
por: de Jong, Birgitta, et al.
Publicado: (2006)

The cancer burden and cancer control in developing countries
por: Pisani, Paola
Publicado: (2011)

Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries
por: Mallafré-Larrosa, Meritxell, et al.
Publicado: (2023)

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
por: Fundytus, Adam, et al.
Publicado: (2021)

Telemedicine and Cancer Care in Low- and Middle-Income Countries During the SARS-CoV-2 Pandemic
por: Yadav, Kavita, et al.
Publicado: (2021)

Impact of Strategies for Mitigating Delays and Disruptions in Cancer Care Due to COVID-19: Systematic Review
por: Pacheco, Rafael Leite, et al.
Publicado: (2021)

Feasibility, Acceptability, and Efficacy of a Community Health Worker–Driven Approach to Screen Hard-to-Reach Periurban Women Using Self-Sampled HPV Detection Test in India
por: Poli, Usha Rani, et al.
Publicado: (2020)

Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials
por: Ibrahim Khalil, Ahmadaye, et al.
Publicado: (2023)

Patterns of care of breast cancer patients in Morocco – A study of variations in patient profile, tumour characteristics and standard of care over a decade
por: Mrabti, Hind, et al.
Publicado: (2021)

Fragility index and fragility quotient in randomized clinical trials
por: Garcia, Marcos Vinicius Fernandes, et al.
Publicado: (2023)

Fragile X/Cancer Cytogenetics
por: Seashore, Margretta R.
Publicado: (1992)

Reply to: Chronic pain assessment and management during post-treatment follow up should be considered as a high value quality indicator for specialist breast cancer center
por: Mrabti, Hind, et al.
Publicado: (2021)

Knowledge Summaries for Comprehensive Breast Cancer Control
por: Zujewski, Jo Anne, et al.
Publicado: (2017)

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
por: Riera, Rachel, et al.
Publicado: (2021)

COVID-19 in Yemen: preparedness measures in a fragile state
por: Dureab, Fekri, et al.
Publicado: (2020)

The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
por: Dyba, Tadeusz, et al.
Publicado: (2021)

COVID-19: A novel burden on the fragile health system of Angola
por: Gyeltshen, Dawa, et al.
Publicado: (2021)

The oncological relevance of fragile sites in cancer
por: Simpson, Benjamin S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ecfag2ofs296sr0urj059l048v